⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2025

Figure S3 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites

Tongtong Wu Zhicong Yang Sufan Tang Hongmei Yuan Yang Liu Haiyang Li Nan Liu Zhanwen Huang Yue Chen Zhijun Zhou

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: This work focuses on developing radioactive ligands specific to fibroblasts with albumin-binding sites.
KEY EVIDENCE: The ESI-MS spectrum and HPLC analysis of DOTA-ALB-02 provide robust characterization of the ligands.
APPROACH: Analytical techniques such as ESI-MS and HPLC were employed for precise evaluation of ligand properties.
SIGNIFICANCE: These advancements in targeting fibroblasts could enhance therapeutic strategies in cancer treatment.

Implication

Analysis reveals ESI-MS spectrum and HPLC data for DOTA-ALB-02, indicating insights into fibroblast targeting methods.

Abstract

Figure S3. ESI-MS spectrum and HPLC analysis of DOTA-ALB-02. See main text for corresponding analytical conditions.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d0282 https://doi.org/10.1158/1535-7163.29759950

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S2 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
2Figure S4 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
3Figure S1 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
4Figure S6 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
5Figure S7 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025

Figure S8 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
Figure S5 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
Figure S11 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025